Healthcare
  • 1m
    Vews
  • 1404
    Avg Daily Vews
  • 5767
    Posts
  • 1 Day
  • 1 Week
  • 1 Month
  • 2 Months
  • 6 Months
  • 1 Year
1
Views Today
181
Total Views

According to the study, the global oligonucleotide synthesis market is likely to grow from $1.3 billion in 2016 to $2.7 billion by 2023. Recent technological and other advances, leading to cost effective and rapid synthesis of oligomers, increased government funding and other initiatives, have been driving the global oligonucleotide synthesis ma...

180
0
1
Views Today
177
Total Views

The global anti-aging market is expected to witness 7.7% CAGR during 2017 – 2025. Technological advancements, increase in volume of anti-aging procedures, growing aging population and increase in disposable income have been driving the global anti-aging market. The market is further expected to gain revenue due to increase in anti-aging awarenes...

180
0
1
Views Today
515
Total Views

The study analyzed that the dry eye syndrome therapeutics pipeline comprises approximately 50 drug candidates, of which 11 drug candidates are in Phase III stage of development, 16 drug candidates are in Phase II stage of development, five drug candidates are in Phase I stage, while 17 drug candidates are in Pre-Clinical stage and one drug candi...

520
0
1
Views Today
523
Total Views

The study analyzed that the oral mucositis therapeutics pipeline comprises approximately 18 drug candidates, of which one drug candidate is in Phase III stage of development, while seven drug candidates are in Phase II stage, four drug candidates are in Phase I stage, five drug candidates are in Pre-Clinical stage and one drug candidate is in th...

520
0
1
Views Today
514
Total Views

The study analysed that the Age-related related macular degeneration therapeutics pipeline comprises of approximately 55 drug candidates, of which five drug candidates are in the Phase III stage, 12 drug candidates are in Phase II stage, 11 drug candidates are in Phase I, 24 drug candidates are in Pre-clinical stage, and there are three drug can...

510
0
1
Views Today
424
Total Views

The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates, of which four drug candidates are in Phase III stage, 21 drug candidates are in Phase II stage, 20 drug candidates are in Phase I stage, 11 drug candidates are in Pre-Clinical stage and one drug candidates is in the Discovery stage. Systemic lupus ...

420
0
1
Views Today
430
Total Views

The ulcerative colitis pipeline analysis report covers approximately 89 drug candidates, of which 68 drug candidates are in active stage. Among the active drug candidates, one drug is in NDA filed stage, 11 are in Phase III stage, 28 are in Phase II stage, 13 are in Phase I stage, 14 are in Pre-Clinical stage and one drug is in Discovery stage o...

430
0
1
Views Today
424
Total Views

The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates, of which eight drug candidates are in Phase III stage, 10 drug candidates are in Phase II stage, nine drug candidates Phase I stage, eight in Pre-Clinical stage and two drug candidates are in Discovery stage.

Explore Report Description at: https://www...

420
0
1
Views Today
422
Total Views

The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates, of which one drug candidate is in Phase III stage, five drug candidates are in Phase II stage and three drug candidates are in Pre-Clinical stage. Also, there are two inactive drug candidates and one discontinued drug candidate. IgA nephropathy, also known as B...

420
0
1
Views Today
408
Total Views

The study analyzed that Sjögren’s syndrome pipeline comprises of approximately 42 drug candidates, of which 29 drug candidates are in active stage. Among the active drug candidates, three are in Phase III stage, 10 are in Phase II stage, seven are in Phase I stage and nine are in Pre-Clinical stage. The development of 11 Sjögren’s syndrome drug ...

410
0
1
Views Today
590
Total Views

The study analyzed that the T-cell immunotherapy pipeline comprised of 139 therapeutic candidates, of which 16 are in Phase II stage of development. The high prevalence of cancer across the globe fuels the extensive research and development for the T-cell immunotherapeutic. T-cell immunotherapy is emerging as novel and promising approach for the...

590
0
1
Views Today
572
Total Views

The growth of the global market is largely driven by the increased investment and funding, strong pipeline, and improved safety and efficacy. BGB-A317, a Phase I therapeutic candidate of BeiGene Ltd., gained $75 million funding to continued development of targeted oncology candidate. PD-1 and PD-L1 inhibitors are applicable to a wider range of t...

570
0
1
Views Today
574
Total Views

The study analyzed that the Alzheimer's disease pipeline comprises 89 drug candidates, of which 17 products are in Phase III, 28 products are in Phase II, 28 products are in Phase I, 15 products are in Pre-Clinical stage and one product is in Discovery stage. Alzheimer’s disease is a common type of dementia and a fatal illness. It includes memor...

570
0
1
Views Today
556
Total Views

The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates, of which nine products are in Phase III, 16 products in Phase II, 18 products in Phase I, and three products are in Pre-Clinical stage. The development of 14 ER+ breast cancer drug candidates was found to be inactive, and 14 ...

560
0
1
Views Today
574
Total Views

The study analyzed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, of which three products are in Phase III, three products in Phase II, one product in Phase I, and one product is in Discovery. The development of two BACE inhibitor candidates was found to be inactive, and five products were discontinued. BACE is a cleav...

570
0
2
Views Today
704
Total Views

The global hydrophilic coatings market features a highly fragmented competitive landscape owing to the presence of a large number of vendors, with the leading five vendors accounting cumulatively for only around 20% of the overall market in 2016, states a recent report by Transparency Market Research (TMR). Exhibiting a high level of competition...

700
0
1
Views Today
490
Total Views

The study analyzed that the BET inhibitors pipeline comprised 38 drug candidates, of which 19 were in Pre-Clinical stage of development. The high prevalence of cancer across the globe fuels the extensive research and development for BET inhibitors. BET inhibitor constitutes that class of $@!#%, which prevents interactions between BET proteins, a...

490
0
1
Views Today
465
Total Views

The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15 are in Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. Various $@!#% are being developed as novel and promising therapeutics for the treatment of IPF.

Browse the Re...

470
0
1
Views Today
1k
Total Views

Global Bone Grafts and Substitutes Market Research Report 2017
Bone Grafts and Substitutes
In this report, the global Bone Grafts and Substitutes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into ...

1.4k
0
1
Views Today
729
Total Views

Transparency Market Research (TMR) observes that the global potassium iodide market is moderately concentrated. The key players are focusing on expanding their manufacturing facilities to increase their global share through higher production. Furthermore, collaborations, mergers and acquisitions, and joint ventures will also be key development s...

730
0